[1]
Kumar, A. et al. 2025. A novel phosphodiesterase target as a therapeutic approach: inhibiting DEN-induced hepatocellular carcinoma progression. EXCLI Journal. 24, (Mar. 2025), 407–429. DOI:https://doi.org/10.17179/excli2024-7941.